Anti-NID1/ NID monoclonal antibody

Anti-NID1/ NID antibody for FACS & in-vivo assay

Target products collectionGo to NID1/NID1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2555-Ab-1/ GM-Tg-hg-MP2555-Ab-2Anti-Human NID1 monoclonal antibodyHuman
GM-Tg-rg-MP2555-Ab-1/ GM-Tg-rg-MP2555-Ab-2Anti-Rat NID1 monoclonal antibodyRat
GM-Tg-mg-MP2555-Ab-1/ GM-Tg-mg-MP2555-Ab-2Anti-Mouse NID1 monoclonal antibodyMouse
GM-Tg-cynog-MP2555-Ab-1/ GM-Tg-cynog-MP2555-Ab-2Anti-Cynomolgus/ Rhesus macaque NID1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2555-Ab-1/ GM-Tg-felg-MP2555-Ab-2Anti-Feline NID1 monoclonal antibodyFeline
GM-Tg-cang-MP2555-Ab-1/ GM-Tg-cang-MP2555-Ab-2Anti-Canine NID1 monoclonal antibodyCanine
GM-Tg-bovg-MP2555-Ab-1/ GM-Tg-bovg-MP2555-Ab-2Anti-Bovine NID1 monoclonal antibodyBovine
GM-Tg-equg-MP2555-Ab-1/ GM-Tg-equg-MP2555-Ab-2Anti-Equine NID1 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2555-Ab-1/ GM-Tg-hg-MP2555-Ab-2; GM-Tg-rg-MP2555-Ab-1/ GM-Tg-rg-MP2555-Ab-2;
GM-Tg-mg-MP2555-Ab-1/ GM-Tg-mg-MP2555-Ab-2; GM-Tg-cynog-MP2555-Ab-1/ GM-Tg-cynog-MP2555-Ab-2;
GM-Tg-felg-MP2555-Ab-1/ GM-Tg-felg-MP2555-Ab-2; GM-Tg-cang-MP2555-Ab-1/ GM-Tg-cang-MP2555-Ab-2;
GM-Tg-bovg-MP2555-Ab-1/ GM-Tg-bovg-MP2555-Ab-2; GM-Tg-equg-MP2555-Ab-1/ GM-Tg-equg-MP2555-Ab-2
Products NameAnti-NID1 monoclonal antibody
Formatmab
Target NameNID1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NID1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NID1/ NID VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2555
    Target NameNID1
    Gene ID4811,18073,25494,711154,488958,101081166,534319,100058173
    Gene Symbol and SynonymsA630025O17,entactin,entactin-1,NID,NID1,nidogen-1
    Uniprot AccessionP14543,P08460
    Uniprot Entry NameNID1_HUMAN,NID1_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseOvary Cancer
    Gene EnsemblENSG00000116962
    Target ClassificationN/A

    The target: NID1, gene name: NID1, also named as NID. This gene encodes a member of the nidogen family of basement membrane glycoproteins. The protein interacts with several other components of basement membranes, and may play a role in cell interactions with the extracellular matrix. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.